EdgarLookup

Prologis, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Prologis, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
147.7%
Profit Margin
Net income ÷ revenue
3.4%
Return on Assets
Net income ÷ assets
0.77x
Debt-to-Equity
Total liabilities ÷ equity
+1.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.25B Feb 13, 2026
FY2025 Sep 30, 2025 $2.21B Feb 13, 2026
FY2025 Jun 30, 2025 $2.18B Feb 13, 2026
FY2025 Mar 31, 2025 $2.14B Feb 13, 2026
FY2025 Dec 31, 2024 $2.20B Feb 13, 2026
FY2025 Sep 30, 2024 $2.04B Feb 13, 2026
FY2025 Jun 30, 2024 $2.01B Feb 13, 2026
FY2025 Mar 31, 2024 $1.96B Feb 13, 2026
FY2024 Dec 31, 2023 $1.89B Feb 14, 2025
FY2024 Sep 30, 2023 $1.91B Feb 14, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.33B Feb 13, 2026
FY2025 Dec 31, 2024 $3.73B Feb 13, 2026
FY2025 Dec 31, 2023 $3.06B Feb 13, 2026
FY2024 Dec 31, 2022 $3.36B Feb 14, 2025
FY2023 Dec 31, 2021 $2.94B Feb 13, 2024
FY2022 Dec 31, 2020 $1.48B Feb 14, 2023
FY2021 Dec 31, 2019 $1.57B Feb 9, 2022
FY2020 Dec 31, 2018 $1.65B Feb 11, 2021
FY2019 Dec 31, 2017 $1.65B Feb 11, 2020
FY2018 Dec 31, 2016 $1.21B Feb 13, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.63B Feb 13, 2026
FY2025 Sep 30, 2025 $940.26M Feb 13, 2026
FY2025 Jun 30, 2025 $912.71M Feb 13, 2026
FY2025 Mar 31, 2025 $878.41M Feb 13, 2026
FY2025 Dec 31, 2024 $1.42B Feb 13, 2026
FY2025 Sep 30, 2024 $1.25B Feb 13, 2026
FY2025 Jun 30, 2024 $1.02B Feb 13, 2026
FY2025 Mar 31, 2024 $720.36M Feb 13, 2026
FY2024 Dec 31, 2023 $834.85M Feb 14, 2025
FY2024 Sep 30, 2023 $882.11M Feb 14, 2025

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.01B Feb 13, 2026
FY2025 Dec 31, 2024 $4.91B Feb 13, 2026
FY2025 Dec 31, 2023 $5.37B Feb 13, 2026
FY2024 Dec 31, 2022 $4.13B Feb 14, 2025
FY2023 Dec 31, 2021 $3.00B Feb 13, 2024
FY2022 Dec 31, 2020 $2.94B Feb 14, 2023
FY2021 Dec 31, 2019 $2.26B Feb 9, 2022
FY2020 Dec 31, 2018 $1.80B Feb 11, 2021
FY2019 Dec 31, 2017 $1.69B Feb 11, 2020
FY2018 Dec 31, 2016 $1.42B Feb 13, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $98.72B Feb 13, 2026
FY2025 Dec 31, 2024 $95.33B Feb 13, 2026
FY2024 Dec 31, 2023 $93.02B Feb 14, 2025
FY2023 Dec 31, 2022 $87.90B Feb 13, 2024
FY2022 Dec 31, 2021 $58.49B Feb 14, 2023
FY2021 Dec 31, 2020 $56.07B Feb 9, 2022
FY2020 Dec 31, 2019 $40.03B Feb 11, 2021
FY2019 Dec 31, 2018 $38.42B Feb 11, 2020
FY2018 Dec 31, 2017 $29.48B Feb 13, 2019
FY2017 Dec 31, 2016 $30.25B Feb 15, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $40.97B Feb 13, 2026
FY2025 Dec 31, 2024 $36.71B Feb 13, 2026
FY2024 Dec 31, 2023 $35.20B Feb 14, 2025
FY2023 Dec 31, 2022 $30.03B Feb 13, 2024
FY2022 Dec 31, 2021 $20.74B Feb 14, 2023
FY2021 Dec 31, 2020 $19.74B Feb 9, 2022
FY2020 Dec 31, 2019 $13.96B Feb 11, 2021
FY2019 Dec 31, 2018 $12.62B Feb 11, 2020
FY2018 Dec 31, 2017 $10.78B Feb 13, 2019
FY2017 Dec 31, 2016 $11.79B Feb 15, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $53.19B Feb 13, 2026
FY2025 Dec 31, 2024 $53.95B Feb 13, 2026
FY2024 Dec 31, 2023 $53.18B Feb 14, 2025
FY2023 Dec 31, 2022 $53.24B Feb 13, 2024
FY2022 Dec 31, 2021 $33.43B Feb 14, 2023
FY2021 Dec 31, 2020 $31.97B Feb 9, 2022
FY2020 Dec 31, 2019 $22.65B Feb 11, 2021
FY2019 Dec 31, 2018 $22.30B Feb 11, 2020
FY2018 Dec 31, 2017 $15.63B Feb 13, 2019
FY2017 Dec 31, 2016 $14.99B Feb 15, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($902.43M) Feb 13, 2026
FY2025 Dec 31, 2024 ($465.91M) Feb 13, 2026
FY2024 Dec 31, 2023 ($627.07M) Feb 14, 2025
FY2023 Dec 31, 2022 ($457.70M) Feb 13, 2024
FY2022 Dec 31, 2021 ($1.33B) Feb 14, 2023
FY2021 Dec 31, 2020 ($2.39B) Feb 9, 2022
FY2020 Dec 31, 2019 ($2.15B) Feb 11, 2021
FY2019 Dec 31, 2018 ($2.38B) Feb 11, 2020
FY2018 Dec 31, 2017 ($2.90B) Feb 13, 2019
FY2017 Dec 31, 2016 ($3.61B) Feb 15, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.15B Feb 13, 2026
FY2025 Dec 31, 2024 $1.32B Feb 13, 2026
FY2025 Dec 31, 2023 $530.00M Feb 13, 2026
FY2024 Dec 31, 2022 $278.00M Feb 14, 2025
FY2023 Dec 31, 2021 $556.00M Feb 13, 2024
FY2022 Dec 31, 2020 $598.00M Feb 14, 2023
FY2021 Dec 31, 2019 $1.09B Feb 9, 2022
FY2021 Dec 31, 2018 $343.86M Feb 9, 2022
FY2020 Dec 31, 2017 $447.05M Feb 11, 2021
FY2019 Dec 31, 2016 $807.32M Feb 11, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $35.04B Feb 13, 2026
FY2025 Dec 31, 2024 $30.88B Feb 13, 2026
FY2024 Dec 31, 2023 $29.00B Feb 14, 2025
FY2023 Dec 31, 2022 $23.88B Feb 13, 2024
FY2023 Dec 31, 2021 $215.30M Feb 13, 2024
FY2021 Dec 31, 2020 $16.85B Feb 9, 2022
FY2020 Dec 31, 2019 $11.91B Feb 11, 2021
FY2019 Dec 31, 2018 $11.09B Feb 11, 2020
FY2018 Dec 31, 2017 $9.41B Feb 13, 2019
FY2017 Dec 31, 2016 $10.61B Feb 15, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 13, 2026
FY2025 Sep 30, 2025 0 Feb 13, 2026
FY2025 Jun 30, 2025 0 Feb 13, 2026
FY2025 Mar 31, 2025 0 Feb 13, 2026
FY2025 Dec 31, 2024 1 Feb 13, 2026
FY2025 Sep 30, 2024 1 Feb 13, 2026
FY2025 Jun 30, 2024 0 Feb 13, 2026
FY2025 Mar 31, 2024 0 Feb 13, 2026
FY2024 Dec 31, 2023 0 Feb 14, 2025
FY2024 Sep 30, 2023 0 Feb 14, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 13, 2026
FY2025 Sep 30, 2025 0 Feb 13, 2026
FY2025 Jun 30, 2025 0 Feb 13, 2026
FY2025 Mar 31, 2025 0 Feb 13, 2026
FY2025 Dec 31, 2024 1 Feb 13, 2026
FY2025 Sep 30, 2024 1 Feb 13, 2026
FY2025 Jun 30, 2024 0 Feb 13, 2026
FY2025 Mar 31, 2024 0 Feb 13, 2026
FY2024 Dec 31, 2023 0 Feb 14, 2025
FY2024 Sep 30, 2023 0 Feb 14, 2025

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 929.15M Feb 13, 2026
FY2025 Dec 31, 2024 926.28M Feb 13, 2026
FY2024 Dec 31, 2023 924.39M Feb 14, 2025
FY2023 Dec 31, 2022 923.14M Feb 13, 2024
FY2022 Dec 31, 2021 739.83M Feb 14, 2023
FY2021 Dec 31, 2020 739.38M Feb 9, 2022
FY2020 Dec 31, 2019 631.80M Feb 11, 2021
FY2019 Dec 31, 2018 629.62M Feb 11, 2020
FY2018 Dec 31, 2017 532.19M Feb 13, 2019
FY2017 Dec 31, 2016 528.67M Feb 15, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 $552.17M Feb 26, 2014
FY2012 Dec 31, 2012 $520.25M Feb 28, 2013
FY2011 Dec 31, 2011 ($387.13M) Feb 29, 2012
FY2011 Dec 31, 2010 $280.66M Feb 29, 2012
FY2011 Dec 31, 2009 $271.85M Feb 29, 2012